Skip to main content

LUP Student Papers

LUND UNIVERSITY LIBRARIES

The Medicinal Mandate: Legal and Policy Implications of Compulsory Licensing on Patented Pharmaceuticals in the European Union to Encourage Access to Medicine during Cross Border Health Crises

Alhaideri, Wan Karwan Mumtaz LU (2023) HARN63 20231
Department of Business Law
Abstract (Swedish)
Patented pharmaceuticals limit medicine access; Compulsory Licensing bridges the gap between Intellectual Property Rights and the Right to Health. The COVID-19 Pandemic sparked debates on medicine access and prompted legal revisions for improved systems. The European Union strives to enhance Intellectual Property Rights and Human Rights, yet current Compulsory Licensing has flaws that hinder medicine access. Respectively, this thesis investigated the efficiency of Compulsory Licensing in the European Union and proposed legal and policy implications to enhance access to medicine during cross-border health crises. This has been carried out with a normative legal method with the support of relevant material such as legal documents and... (More)
Patented pharmaceuticals limit medicine access; Compulsory Licensing bridges the gap between Intellectual Property Rights and the Right to Health. The COVID-19 Pandemic sparked debates on medicine access and prompted legal revisions for improved systems. The European Union strives to enhance Intellectual Property Rights and Human Rights, yet current Compulsory Licensing has flaws that hinder medicine access. Respectively, this thesis investigated the efficiency of Compulsory Licensing in the European Union and proposed legal and policy implications to enhance access to medicine during cross-border health crises. This has been carried out with a normative legal method with the support of relevant material such as legal documents and legislations, case law, and scholarly articles. The thesis addressed the need for more harmonization between its Member States, a shaky foundation offered by connecting legal considerations and import and export concerns. It proposed establishing a harmonized and stable framework at the Union level, granting the European Union the authority to generate a Union-based Compulsory Licensing. It emphasized the importance of considering leading factors, such as a more unified patent system and crisis management strategies at the Union level, and improving import and export processes under Compulsory Licensing by setting legal grounds with the ultimate goal of access to medicine within any geography where accessibility is vital. (Less)
Please use this url to cite or link to this publication:
author
Alhaideri, Wan Karwan Mumtaz LU
supervisor
organization
course
HARN63 20231
year
type
H1 - Master's Degree (One Year)
subject
keywords
Compulsory Licensing, Access to Medicine, TRIPS Agreement, Regulation (EC) No 816/2006, International Law, European Union Law.
language
English
id
9122240
date added to LUP
2023-06-20 14:18:54
date last changed
2023-06-20 14:18:54
@misc{9122240,
  abstract     = {{Patented pharmaceuticals limit medicine access; Compulsory Licensing bridges the gap between Intellectual Property Rights and the Right to Health. The COVID-19 Pandemic sparked debates on medicine access and prompted legal revisions for improved systems. The European Union strives to enhance Intellectual Property Rights and Human Rights, yet current Compulsory Licensing has flaws that hinder medicine access. Respectively, this thesis investigated the efficiency of Compulsory Licensing in the European Union and proposed legal and policy implications to enhance access to medicine during cross-border health crises. This has been carried out with a normative legal method with the support of relevant material such as legal documents and legislations, case law, and scholarly articles. The thesis addressed the need for more harmonization between its Member States, a shaky foundation offered by connecting legal considerations and import and export concerns. It proposed establishing a harmonized and stable framework at the Union level, granting the European Union the authority to generate a Union-based Compulsory Licensing. It emphasized the importance of considering leading factors, such as a more unified patent system and crisis management strategies at the Union level, and improving import and export processes under Compulsory Licensing by setting legal grounds with the ultimate goal of access to medicine within any geography where accessibility is vital.}},
  author       = {{Alhaideri, Wan Karwan Mumtaz}},
  language     = {{eng}},
  note         = {{Student Paper}},
  title        = {{The Medicinal Mandate: Legal and Policy Implications of Compulsory Licensing on Patented Pharmaceuticals in the European Union to Encourage Access to Medicine during Cross Border Health Crises}},
  year         = {{2023}},
}